将视神经纳入多发性硬化诊断标准:一项纵向、前瞻性、多中心研究
该前瞻性多中心研究纳入157例临床孤立综合征患者,评估视神经MRI、光学相干断层扫描和视觉诱发电位检测视神经受累的能力,并分析将视神经作为第五个中枢神经系统区域纳入2017 McDonald诊断标准中空间多发性标准的贡献。结果显示视神经病变常见,修改后的空间多发性标准敏感性更高但特异性略低,总体准确率相似,支持将视神经作为第五个区域纳入空间多发性标准。
要点
- 视神经MRI在入组时发现40.2%的临床孤立综合征患者存在视神经受累,视神经炎患者中达72.5%。
- 修改后的空间多发性标准(加入视神经)敏感性92.5%(含视神经MRI)vs 88.2%,特异性80.0%(含GCIPL IEA ≥4 μm)vs 82.2%,总体准确率86.6% vs 86.5%。
- 研究支持将视神经作为第五个区域纳入空间多发性标准。
核心结论
- 在临床孤立综合征患者中,由MRI、OCT或VEP定义的视神经病变频繁被检测到,尤其在表现为视神经炎时。
研究设计与样本
- 前瞻性、多中心队列研究,纳入5个MAGNIMS中心的157例临床孤立综合征患者,在发病6个月内接受至少2项视觉评估(视神经MRI、OCT或VEP)。
主要发现
- 60/157(38.2%)患者表现为视神经炎。
- 入组时视神经MRI显示40.2%患者存在视神经受累,视神经炎患者中为72.5%。
- 随访(平均27.9个月,标准差14.5)时,111/157(70.7%)患者根据2017 McDonald标准诊断为多发性硬化。
- 满足2017空间多发性标准或任何修改的空间多发性标准对主要和次要结局均赋予相似的高风险。
- 修改的空间多发性标准敏感性更高(92.5%[含视神经MRI] vs 88.2%),但特异性略低(80.0%[含GCIPL IEA ≥4 μm] vs 82.2%),总体准确率相似(86.6%[含视神经MRI] vs 86.5%)。
关键数值与推荐
- 修改的空间多发性标准通过将视神经区域(由每项检查单独定义及其任意组合)作为第五个中枢神经系统区域加入而构建。
- 主要结局为根据2017 McDonald标准诊断多发性硬化;次要结局为新发T2病灶和/或第二次复发。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The optic nerve is not one of the areas of the CNS that can be used to demonstrate dissemination in space (DIS) within the 2017 McDonald criteria for the diagnosis of multiple sclerosis (MS). Objectives were (1) to assess whether optic nerve-MRI (ON-MRI), optical coherence tomography (OCT), and visual evoked potentials (VEP) detect optic nerve involvement in clinically isolated syndrome (CIS) and (2) to evaluate the contribution of the optic nerve topography to the current diagnostic criteria in a prospective, multicenter cohort. METHODS: MAGNIMS centers were invited to provide prospective data on patients with CIS who underwent a visual assessment with at least 2 of 3 investigations (ON-MRI, OCT, or VEP) within 6 months of onset. Modified DIS criteria were constructed by adding the optic nerve topography, defined by each investigation separately and any combination of them, as the fifth area of the CNS. A risk assessment analysis and the performance of the different DIS criteria were analyzed using the diagnosis of MS according to the 2017 McDonald criteria as the primary outcome and new T2 lesions and/or a second relapse as the secondary outcome. RESULTS: We included 157 patients with CIS from 5 MAGNIMS centers; 60/157 (38.2%) patients presented with optic neuritis. Optic nerve involvement on ON-MRI was found in 40.2% patients at study entry and in 72.5% of those with optic neuritis.At follow-up (mean 27.9 months, SD 14.5), 111/157 patients (70.7%) were diagnosed with MS according to the 2017 McDonald criteria. Fulfilling either 2017 DIS or any modified DIS criteria conferred a similar high risk for reaching primary and secondary outcomes. The modified DIS criteria had higher sensitivity (92.5% [with ON-MRI] vs 88.2%), but slightly lower specificity (80.0% [with GCIPL IEA ≥4 μm] vs 82.2%), with overall similar accuracy (86.6% [with ON-MRI] vs 86.5%) than 2017 DIS criteria. Consistent results were found for secondary outcomes. DISCUSSION: In patients with CIS, the presence of an optic nerve lesion defined by MRI, OCT, or VEP is frequently detected, especially when presenting with optic neuritis. Our study supports the addition of the optic nerve as a fifth topography to fulfill DIS criteria.
引用
- Vidal-Jordana A, Rovira A, Calderon W, et al. Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study. Neurology. 2023. PMID: 38165378. doi:10.1212/WNL.0000000000207805
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。